Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
: Delisting from New York Stock Exchange and ticker change - EconoTimes)
Reference is made to Marine Harvest's stock exchange announcement on 15 February 2017 where the company announced its intention to delist its American Depository Shares ("ADSs") from the New York Stock Exchange. The ADSs have now been delisted. The ADSs are tradable in the OTC market in the US under a new ticker MHGVY.
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
